Biochemical characterization of a new disintegrin, flavostatin, isolated from Trimeresurus flavoviridis venom

Biochimie

Volumn 78, Issue 4, 1996, Pages 245-252

  Kawasaki, T ^a   Sakai, Y ^a   Taniuchi, Y ^a   Sato, K ^a   Maruyama, K ^a   Shimizu, M ^a   Kaku, S ^a   Yano, S ^a   Inagaki, O ^a   Tomioka, K ^a   Yanagisawa, I ^a   Takenaka, T ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

FITC conjugated disintegrin; GPIIb IIIa; High shear stress induced platelet aggregation; Snake venom

Indexed keywords

4 [4 [4 (AMINOIMINOMETHYL)PHENYL] 1 PIPERAZINYL] 1 PIPERIDINEACETIC ACID; ABCIXIMAB; ADENOSINE DIPHOSPHATE; COLLAGEN; DISINTEGRIN; FIBRINOGEN; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; FLUORESCEIN ISOTHIOCYANATE; N ACETYLCYSTEINYLASPARAGINYLPROLYLARGINYLGLYCYLASPARTYL(O METHYLTYROSYL)ARGINYLCYSTEINAMIDE CYCLIC 1,9 DISULFIDE; POLYPEPTIDE; SNAKE VENOM; THROMBIN RECEPTOR ACTIVATING PEPTIDE; TIROFIBAN;

ARTICLE; BINDING COMPETITION; BIOCHEMISTRY; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN ANALYSIS; SNAKE; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE RICH PLASMA;

SERPENTES; TRIMERESURUS FLAVOVIRIDIS;

EID: 0029827985     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/0300-9084(96)82187-0     Document Type: Article

References (49)

1. 1 Plow EF, Marguerie G, Ginsberg M (1987) Fibrinogen, fibrinogen receptors, and the peptides that inhibit these interactions. Biochem Pharmacol 36, 4035-4040
2. 2 Phillips DR, Charo IF, Parise LV, Fitzgerald LA (1988) The platelet membrane glycoprotein IIb-IIIa complex. Blood 71, 831-843
3. 3 Hynes RO (1987) Integrins: a family of cell surface receptors. Cell 48 549-554
4. 4 Yost HJ (1992) Regulation of vertebrate left-right asymmetries by extracellular matrix. Nature 357, 158-161
5. 5 Ruoslahti E, Pierschbacher MD (1987) New perspectives in cell adhesion: RGD and integrins. Science 238, 491-497
6. 6 Coller BS, Folts JD, Scudder LE, Smith SR (1986) Antithrombotic effect of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor in an experimental animal model. Blood 68, 783-786
7. 7 Hanson SR, Pareti FI, Ruggeri ZM, Marzec UM, Kunicki TJ, Montgomery RR, Zimmerman TS, Harker LA (1988) Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon. J Clin Invest 81, 149-158
8. 8 Kaku S, Kawasaki T, Sakai Y, Taniuchi Y, Yano S, Suzuki K, Terazaki C, Kawamura K, Masuho Y, Satoh N, Takenaka T, Yanagi K, Ohshima N (1995) Antithrombotic effect of a humanized anti-GPIIb/IIIa monoclonal antibody, YM207, in a photochemically induced thrombosis model in monkeys. Eur J Pharmacol 279, 115-121
9. 9 Shebuski RJ, Ramjit DR, Bencen GH, Polokoff MA (1989) Characterization and platelet inhibitory activity of bitistatin, a potent argininglycine-aspartic acid-containing peptide from the venom of the viper Bitis arietans. J Biol Chem 264, 21550-21556
10. 10 Chao BH, Jakubowski JA, Savage B, Chow EP, Marzec UM, Harker LA, Maraganore JM (1989) Agkistrodon piscivorus piscivorus platelet aggregation inhibitor: a potent inhibitor of platelet activation. Proc Natl Acad Sci USA 86, 8050-8054
11. 11 Gan Z-R, Gould RJ, Jacobs JW, Friedman PA, Polokoff MA (1988) Echistatin: a potent platelet aggregation inhibitor from the venom of the viper, Echis carinatus. J Biol Chem 263, 19827-19832
12. 12 Huang T-F, Holt JC, Lukasiewicz H, Niewiarowski S (1987) Trigramin: a low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex. J Biol Chem 262, 16157-16163
13. 13 Scarborough RM, Rose JW, Hsu MA, Phillips DR, Fried VA, Campbell AM, Nannizzi L, Charo IF (1991) Barbourin: a GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m barbouri. J Biol Chem 266, 9359-9362
14. 14 Tcheng JE, Harrington RA, Kottke-Marchant K, Kleiman NS, Ellis SG, Kereiakes DJ, Mick MJ, Navetta FI, Smith JE, Worley SJ, Miller JA, Joseph DM, Sigmon KN, Kitt MM, du Mee CP, Califf RM, Topol EJ (1995) Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker integrelin in elective coronary intervention. Circulation 91, 2151-2157
15. 15 Mousa SA, Bozarth JM, Forsythe MS, Jackson SM, Leamy A, Diemer MM, Kapil RP, Knabb RM, Mayo MC, Piece SK, De Grado WF, Thoolen MJ, Reilly TM (1994) Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist. Circulation 89, 3-12
16. 16 Yasuda T, Gold HK, Kohmura C, Guerrero L, Yaoita H, Fallon JT, Bunting S, Collen D (1993) Intravenous and endobronchial administration of G4120, a cyclic Arg-Gly-Asp-containing platelet GPIIb/IIIa receptor-blocking pentapeptide, enhances and sustains coronary arterial thrombolysis with rt-PA in a canine preparation. Arterioscler Thromb 13, 738-747
17. 17 Peerlinck K, Lepeleire ID, Goldberg M, Farrel D, Barrett J, Hand E, Panebianco D, Deckmyn H, Vermylen J, Arnout J (1993) MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in man. Circulation 88, 1512-1517
18. 18 Carteaux J-P, Steiner B, Roux S (1993) Ro44-9883, a new non-peptidic GPIIb/IIIa antagonist prevents platelet loss in a guinea pig model of extracorporeal circulation. Thromb Haemost 70, 817-821
19. 19 Nicholson NS, Panzer-Knodle SG, Salyers AK, Taite BB, Szalony JA, Haas NF, King LW, Zablocki JA, Keller BT, Broschat K, Engleman VW, Herin M, Jacqmin P, Feiden LP (1995) SC-54684A: an orally active inhibitor of platelet aggregation. Circulation 91, 403-410
20. 20 Goto S, Ikeda Y, Murata M, Handa M, Takahashi E, Yoshioka A, Fujimura Y, Fukuyama M, Handa S, Ogawa S (1992) Epinephrin augments von Willebrand factor dependent shear-induced platelet aggregation. Circulation 86, 1859-1863
21. 21 Ikeda Y, Handa M, Kawano K, Kamata T, Murata M, Araki Y, Anbo H, Kawai Y, Watanabe K, Itagaki I, Sakai K, Ruggeri ZM (1991 ) The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest 87, 1234-1240
22. 22 Huang T-F, Sheu J-R, Teng C-M, Chen S-W, Liu C-S (1991) Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb/IIIa complex. J Biochem 109, 328-334
23. 23 Musial J, Niewiarowski S, Rucinski B, Stewart GJ, Cook JJ, Williams JA, Edmunds Jr LH (1990) Inhibition of platelet adhesion to surfaces of extracorporeal circuits by disintegrins: RGD-containing peptides from snake venoms. Circulation 82, 261-273
24. 24 Topol EJ, Plow EF (1993) Clinical trials of platelet receptor inhibitors. Thromb Haemost 70, 94-98
25. 25 Wilson JM, Ferguson JJ (1994) The therapeutic potential of abciximab (c7E3 Fab) in percutaneous transluminal coronary angioplasty. Implications of EPIC study. Clin Immunother 1, 1-7
26. 26 Coller BS, Folts JD, Smith SR, Scudder LE, Jordan R (1989) Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, platelet aggregation, and blockade of GPIIb/IIIa receptors. Circulation 80, 1766-1774
27. 27 Kaku S, Kawasaki T, Hisamichi N, Sakai Y, Taniuchi Y, Inagaki O, Yano S, Suzuki K, Terazaki C, Masuho Y, Satoh N, Takenaka T (1995) Antithrombotic effect of the Fab fragment of the humanized anti-GPIIb/IIIa monoclonal antibody C4G1 with little effect on bleeding time. Thromb Haemost 73, 1314 (abstract #1589)
28. III. J Biochem 116, 778-786
29. 29 Huang TF, Sheu JR, Teng CM (1991) A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom. Biochem J 277, 351-357
30. IIbβIII receptor blockage with peptide TP9201 prevents platelet uptake on Dacron vascular grafts without significant effect on bleeding time. J Lab Clin Med 124, 589-599
31. 31 Barrett JS, Murphy G, Peerlinck K, De Lepeleire I, Gould RJ, Panebianco D, Hand E, Deckmyn H, Vermylen J, Arnout J (1994) Pharmacokinetics and pharmacodynamics of MK-383, a selective non-peptide platelet glycoprotein-IIb/IIIa receptor antagonist, in healthy men. Clin Pharmacol Ther 56,377-388
32. 32 Foster MR, Pike NB, Hornby EJ, Porter B, Eldred CD, Ross BC, Lumley P (1993) GR144053, a potent and specific non-peptide fibrinogen receptor antagonist on human platelets in vitro. Thromb Haemost 69, 559 (abstract #64)
33. 33 Fujimura Y, Titani K, Usami Y, Suzuki M, Oyama R, Matsui T, Fukui H, Sugimoto M, Ruggeri ZM (1991) Isolation and chemical characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of Bothrops jararaca. Biochemistry 30, 1957-1964
34. 34 Gould RJ, Polokoff MA, Friedman PA, Huang T-F, Holt JC, Cook JJ, Niewiarowski S (1990) Disintegrins: a family of integrin inhibitory proteins from viper venoms. Proc Soc Expt Biol Med 195, 168-171
35. 35 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265-275
36. 36 Co MS, Yano S, Hsu RK, Landolfi NF, Vasquez M, Cole M, Tso JT, Bringman T, Laird W, Hudson D, Kawamura K, Suzuki K, Furuichi K, Queen C, Masuho Y (1994) A humanized antibody specific for the platelet integrin GPIIb/IIIa. J Immunol 152, 2968-2976
37. 37 Egberson MS, Laswell WL, Hartman GD, Duggan ME, Halczenko W (1992) Novel sulfonamide fibrinogen receptor antagonists. EP 0 478 363 A2
38. 38 Porter B, Eldred CD, Kelly HA and Wheatcroft JR (1993) Piperdine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation. WO 9310091
39. 39 Katagiri Y, Hayashi Y, Yamamoto K, Tanoue K, Kosaki G, Yamazaki H (1990) Localization of von Willebrand factor and thrombin-interactive domains on human platelet glycoprotein Ib. Thromb Haemost 63, 122-126
40. 40 MacFarlane DE, Stibbe J, Kirby E, Zucker MB, Grant RA, McPherson J (1975) A method for assaying von Willebrand factor (ristocetin cofactor). Thromb Diath Haemorrh 34, 306-308
41. 41 Fitzgerald LA, Leung B, Phillips DR (1985) A method for purifying platelet membrane glycoprotein IIb-IIIa complex. Anal Biochem 151, 169-177
42. 42 Liu C-Z, Wang Y-W, Shen M-C, Huang T-F (1994) Analysis of human platelet glycoprotein IIb-IIIa by fluorescein isothiocyanate-conjugated disintegrins with flow cytometry. Thromb Haemost 72, 919-925
43. 43 Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51, 660-672
44. 44 Peterson DM, Stathopoulos NA, Giorgio TD, Moake JL (1987) Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoprotein Ib and IIb-IIIa. Blood 69, 625-628
45. 45 Folts JD, Gallagher K, Rowe GG (1982) Blood flow reductions in stenosed canine coronary arteries: vasospasm or platelet aggregation? Circulation 65, 248-255
46. 46 Huang T-F, Liu C-Z, Ouyang C, Teng C-M (1991) Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist. Biochem Pharmacol 42, 1209-1219
47. 47 Coller BS (1986) Activation affects access to the platelet receptor for adhesive glycoproteins. J Cell Biol 103, 451-456
48. 48 Tsao PW, Bozarth JM, Jackson SA, Forsythe MS, Flint SK, Mousa SA (1995) Platelet GPIIb/IIIa receptor occupancy studies using a novel fluoresceinated cyclic Arg-Gly-Asp peptide. Thromb Res 77, 543-556
49. 49 Yano S, Suzuki K, Sato K, Terazaki C, Hisamichi N, Kaku S, Sakai Y, Taniuchi Y, Kawasaki T, Inagaki O, Sugita Y, Satoh N, Takenaka T, Masuho Y (1995) Antiplatelet agent YM337 inhibits platelet function with little effect on bleeding time in monkeys. Blood 86, 912a (abstract #3636)